Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis

Anne Skøttrup Mørkholt; Kenneth Kastaniegaard; Michael Sloth Trabjerg; Gopana Gopalasingam; Wanda Niganze; Michal Krystian Oklinski; Agnete Larsen; Jette G. K. Nieland; Allan Stensballe; Søren Nielsen; John Dirk Nieland

doi:10.7224/1537-2073-19.s1.1

Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis

Anne Skøttrup Mørkholt, Kenneth Kastaniegaard, Michael Sloth Trabjerg, Gopana Gopalasingam, Wanda Niganze, Michal Krystian Oklinski, Agnete Larsen, Jette G. K. Nieland, Allan Stensballe, Søren Nielsen, John Dirk Nieland

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	(NP01)
Journal	International Journal of MS Care
Volume	19
Issue number	Suppl. 1
Pages (from-to)	54
ISSN	1537-2073
DOIs	https://doi.org/10.7224/1537-2073-19.s1.1
Publication status	Published - 2017
Event	Annual Meeting of the Consortium of Multiple Sclerosis Centers, CMSC - New Orleans, LA, United States Duration: 24 May 2017 → 27 May 2017

Conference

Conference	Annual Meeting of the Consortium of Multiple Sclerosis Centers, CMSC
Country/Territory	United States
City	New Orleans, LA
Period	24/05/2017 → 27/05/2017

Access to Document

10.7224/1537-2073-19.s1.1

AUB Link

Search for the material in Aalborg University Library's search engine

1 PhD thesis

Carnitine Palmitoyl Transferase 1 – a Potential Target to Restore Dysregulated Metabolism in Neurodegenerative Diseases? based on in vivo models mimicking Amyotrophic Lateral Sclerosis, Parkinson's Disease and Mutiple Sclerosis
Trabjerg, M., 2020, Aalborg Universitetsforlag. 113 p.
Research output: PhD thesis

Open Access
File

307 Downloads (Pure)

Cite this

Mørkholt, A. S., Kastaniegaard, K., Trabjerg, M. S., Gopalasingam, G., Niganze, W., Oklinski, M. K., Larsen, A., Nieland, J. G. K., Stensballe, A., Nielsen, S., & Nieland, J. D. (2017). Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis. International Journal of MS Care, 19(Suppl. 1), 54. Article (NP01). https://doi.org/10.7224/1537-2073-19.s1.1

@article{e654f5a6a6bb497f92c163b9d9fd4219,

title = "Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis",

author = "M{\o}rkholt, {Anne Sk{\o}ttrup} and Kenneth Kastaniegaard and Trabjerg, {Michael Sloth} and Gopana Gopalasingam and Wanda Niganze and Oklinski, {Michal Krystian} and Agnete Larsen and Nieland, {Jette G. K.} and Allan Stensballe and S{\o}ren Nielsen and Nieland, {John Dirk}",

year = "2017",

doi = "10.7224/1537-2073-19.s1.1",

language = "English",

volume = "19",

pages = "54",

journal = "International Journal of MS Care",

issn = "1537-2073",

publisher = "Consortium of Multiple Sclerosis",

number = "Suppl. 1",

note = "Annual Meeting of the Consortium of Multiple Sclerosis Centers, CMSC ; Conference date: 24-05-2017 Through 27-05-2017",

}

Mørkholt, AS, Kastaniegaard, K, Trabjerg, MS, Gopalasingam, G, Niganze, W, Oklinski, MK, Larsen, A, Nieland, JGK, Stensballe, A, Nielsen, S & Nieland, JD 2017, 'Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis', International Journal of MS Care, vol. 19, no. Suppl. 1, (NP01), pp. 54. https://doi.org/10.7224/1537-2073-19.s1.1

Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis. / Mørkholt, Anne Skøttrup; Kastaniegaard, Kenneth; Trabjerg, Michael Sloth et al.
In: International Journal of MS Care, Vol. 19, No. Suppl. 1, (NP01), 2017, p. 54.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis

AU - Mørkholt, Anne Skøttrup

AU - Kastaniegaard, Kenneth

AU - Trabjerg, Michael Sloth

AU - Gopalasingam, Gopana

AU - Niganze, Wanda

AU - Oklinski, Michal Krystian

AU - Larsen, Agnete

AU - Nieland, Jette G. K.

AU - Stensballe, Allan

AU - Nielsen, Søren

AU - Nieland, John Dirk

PY - 2017

Y1 - 2017

U2 - 10.7224/1537-2073-19.s1.1

DO - 10.7224/1537-2073-19.s1.1

M3 - Conference abstract in journal

SN - 1537-2073

VL - 19

SP - 54

JO - International Journal of MS Care

JF - International Journal of MS Care

IS - Suppl. 1

M1 - (NP01)

T2 - Annual Meeting of the Consortium of Multiple Sclerosis Centers, CMSC

Y2 - 24 May 2017 through 27 May 2017

ER -

Comparison of etomoxir, a lipid metabolism blocker, and interferon beta treatment on antibody recognition of brain proteins in multiple sclerosis

Conference

Access to Document

AUB Link

Research output

Carnitine Palmitoyl Transferase 1 – a Potential Target to Restore Dysregulated Metabolism in Neurodegenerative Diseases? based on in vivo models mimicking Amyotrophic Lateral Sclerosis, Parkinson's Disease and Mutiple Sclerosis

Cite this